SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
10 janv. 2024 07h00 HE
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4...
SANUWAVE Announces Q3 2023 Financial Results
10 nov. 2023 05h00 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
08 nov. 2023 16h30 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference...
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
10 oct. 2023 07h30 HE
|
SANUWAVE Health, Inc.
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist...
SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company
23 août 2023 16h30 HE
|
SANUWAVE Health, Inc.
· SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on...
SANUWAVE Announces Q2 2023 Financial Results
11 août 2023 06h00 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today...
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
09 août 2023 17h22 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live...
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.
01 août 2023 07h30 HE
|
SANUWAVE Health, Inc.
Pacific Medical to bring its sales force of over 215 dedicated representatives covering seven western states to the SANUWAVE UltraMist line of directed energy wound care products. Long-term...
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President
31 juil. 2023 07h30 HE
|
SANUWAVE Health, Inc.
Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led a 170-person contract manufacturing organization EDEN...
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
17 juil. 2023 07h30 HE
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results indicate 16-21% growth rate over Q2 2022, consistent with guidance provided...